A 57-year-old man presents with face, arm, and leg weakness and slurred speech after violent coughing. He has pain over the right eye, which the wife noted as smaller than the left. Diagnosis? Medscape
Category: News
Intra-Arterial Chemo Helps in Advanced Retinoblastoma
Intra-arterial chemotherapy is a safe and effective treatment for advanced retinoblastoma, researchers at one major hospital say. Reuters Health Information
Poorer Vision May Persist After Amblyopia Therapy
Even after successful treatment for amblyopia, people may still have certain vision problems in day-to-day life, a small study suggests. Reuters Health Information
Thrombocytopenia Tied to Death in Critically Ill
In critically ill patients, thrombocytopenia portends an increased risk of death, Canadian researchers report in the February issue of Chest. Reuters Health Information
Safe Use of Drugs Requires Reports From Clinicians
The Safe Use Initiative is taking aim at adverse drug events and seeks input on safety issues encountered by frontline clinicians. Medscape Pharmacists
Cancer Drug Better Than Laser Surgery For Baby Blindness
Bevacizumab is becoming quite popular these days. Aside from treating ovarian cancer, it has been published this week that it also benefits premature infants suffering from blindness or retinopathy of prematurity and is less of a risk than laser surge…
Cancer Drug Better Than Laser Surgery For Baby Blindness
Bevacizumab is becoming quite popular these days. Aside from treating ovarian cancer, it has been published this week that it also benefits premature infants suffering from blindness or retinopathy of prematurity and is less of a risk than laser surge…
Live Webcast Of VEGF-Trap Eye Phase III Trial Results On Mywhitecoat.com
On Saturday, February 12, 2011, more than 200 eye specialists in 10 countries simultaneously viewed both a presentation of results from an important phase III clinical trial and a panel discussion, all from the comfort of their own computer screens. M…
Live Webcast Of VEGF-Trap Eye Phase III Trial Results On Mywhitecoat.com
On Saturday, February 12, 2011, more than 200 eye specialists in 10 countries simultaneously viewed both a presentation of results from an important phase III clinical trial and a panel discussion, all from the comfort of their own computer screens. M…
Inexpensive drug therapy shows promise in treating premature infants with childhood blindness
A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity.
Allergan receives FDA approval for expanded use of LAP-BAND System in adults with obesity
Allergan, today announced the U.S. Food and Drug Administration approved the expanded use of the LAP-BAND System, Allergan’s gastric band, for adults with obesity who have failed more conservative weight reduction alternatives, such as diet and exercis…
Corneal Graft for Keratoconus May Fail Long-Term
Visual acuity outcomes and graft survival after penetrating corneal transplant for keratoconus are good, but younger patients are likely to need repeat transplants during their lifetimes, new research shows. Reuters Health Information
No Ill Effects When High-Risk Prethreshold Retinopathy of Prematurity Is Treated Early
A 6-year follow-up finds no adverse effects on visual field extent in infants who undergo early treatment for high-risk prethreshold retinopathy of prematurity. Medscape Medical News
Drug Bests Laser for Preemie Eye Disorder (CME/CE)
(MedPage Today) — The use of bevacizumab (Avastin) for the treatment of retinopathy of prematurity appears better than conventional laser therapy — and may be a significant advance in a disease that often leads to childhood blindness, results of a pr…
Separating Docs From Industry — A Witch Hunt?
Frank Veith, MD, believes that the initiative to separate physicians from industry is excessive and can lead to harm for patients. What do you think? Medscape General Surgery
E(ye)Brain Launches Mobile Eye-Tracking Device for Early Neuro Diagnosis
French startup E(ye)Brain, in collaboration with neurologists at La Pitié-Salpêtrière Hospital in Paris, has been working on a video-oculography measurement technology for early diagnosis of neurological diseases. The company has re…
Giffords Recovering Speech, May Attend April Shuttle Launch
The procedure to replace the skull section that was removed in Giffords’ craniectomy is planned sooner than expected. Medscape Medical News
FDA Recalls Triad Lubricating Jelly Packages Due to Infection Concerns
A class II recall issued on Triad lubricating jelly packages follows a recall last month of potentially contaminated alcohol swabs by the same company. Medscape Medical News
E(ye)Brain Launches Mobile Eye-Tracking Device for Early Neuro Diagnosis
French startup E(ye)Brain, in collaboration with neurologists at La Pitié-Salpêtrière Hospital in Paris, has been working on a video-oculography measurement technology for early diagnosis of neurological diseases. The company has recently announced that its Mobile Eye Brain Tracker will soon be hitting the market, probably in Europe and elsewhere, except for the United States where no FDA clearance has been given to the device. The company hopes that its technology will be validated for early diagnosis in a range of disorders, such as progressive supranuclear palsy, corticobasal degeneration, multiple sclerosis, and even Parkinson’s.
AMD Research Critical As Experts Question Reported Decline In Prevalence
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50, robbing an estimated 10 million Americans of their sight and independence. Recent publicized findings purport a decline in the prevalence of AMD, but some exper…